Cellular Innate Immunity
Philipp Henneke
Rare Disease Genetics
Miriam Schmidts
Inherited and acquired disorders of primary and secondary hemostasis
Barbara Zieger
Pediatric Sarcomas
Simone Hettmer
Hilda Biobank Freiburg
Hilda Biobank
Pediatric Endocrinology
Karl Otfried Schwab
Systems Biology of Lymphocyte Behavioral Regulation
Jan Rohr
Pediatric epilepsy
Kerstin Alexandra Klotz and Julia Jacobs
Fatty acid oxidation disorders: risk stratification, disease modifiers and metabolic networks
Ute Spiekerkötter
Adaptive Immunity
Oktay Kirak
Improving treatment in glycogen storage diseases and fatty acid oxidation defects
Sarah Grünert
Understanding Vascular Anomalies
Friedrich Kapp
Human T cell Immunodeficiencies
Stephan Ehl
MetaboCF
MetaboCF
Inborn errors of metabolism with a renal phenotype
Anke Schumann
Hematopoiesis and Leukemogenesis
Miriam Erlacher
Mitochondrial fatty acid oxidation and fatty acid biosynthesis
Sara Tucci
Clinical Trials and Registries
Study Office
Rare Blood Disorders and Hematopoietic Stem Cell Transplantation
Brigitte Strahm
Epigenetic Regulation of Stem cells and Cancer
Manching Ku
Metabolism and Cofactor Enzymology
Luciana Hannibal
Pediatric Healthcare Research
Thorsten Langer
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies
Carsten Speckmann
Neuromuscular Diseases in Children and Adolescents
Astrid Pechmann
EPIdiagnosis and EPItherapy of juvenile myelomonocytic leukemia
Christian Flotho
Research is central to the work of the Freiburg Center for Pediatrics and Adolescent Medicine. Our research strengths represent a wide spectrum of pediatric research. Our basic and translational research stimulates new understandings of disease mechanisms and inspires new approaches to treatment. Through our clinical research we test novel therapies which have been specifically adapted or newly developed to suit the needs of children and young people. And our healthcare research drives improvements that enable delivery of better care for children and their families in a complex and changing environment.
On the Research pages of this site, our leading researchers showcase their work. For more information about the Freiburg Center for Pediatrics and Adolescent Medicine, please visit our pages on the website of the Freiburg University Medical Center.
About the Freiburg Center for Pediatrics and Adolescent Medicine
Over €4.5 million
In 2018, the Freiburg Center for Pediatrics and Adolescent Medicine received over €4.5 million in external funding and grants.
Four Collaborative Research Centers
The Freiburg Center for Pediatrics and Adolescent Medicine coordinates one and participates in three further DFG-funded Collaborative Research Centers (SFBs):
- SFB 1160 "IMPATH: Immune-mediated pathology as a consequence of impaired immune reactions" (Speaker: Stephan Ehl, Pediatric Immunology)
- SFB 992 "Medical Epigenetics"
- SFB 1140 "KIDGEM: Kidney Disease – from genes to mechanisms"
- SFB/TRR167 "NeuroMac: Development, function and potential of myeloid cells in the central nervous system"
Six European Reference Networks
In association with the Freiburg Center for Rare Diseases, we are involved in six of the European Reference Networks for Rare Diseases:
- ERN-BOND for rare bone diseases
- EURO-NMD for rare neuromuscular diseases
- MetabERN for rare hereditary metabolic disorders
- PaedCan-ERN for pediatric cancer/hemato-oncology
- ERN-RITA for rare immunodeficiency, autoinflammatory and autoimmune diseases
- VASCERN for rare multisystemic vascular diseases.
200 publications
In 2020, our researchers were authors on over 200 scientific publications.
120 clinical trials & registry studies
In 2018, the Freiburg Center for Pediatrics and Adolescent Medicine enrolled participants in over 120 clinical trials and register studies via our Study Office.
Research centers & networks
Researchers from the Freiburg Center for Pediatrics and Adolescent Medicine play a key role in many regional, national and international research centers and graduate colleges, including:
- the German Cancer Research Center (DKTK) and the Comprehensive Cancer Center Freiburg (CCCF)
- the Center for Chronic Immunodeficiency (CCI)
- the PRIMAL Consortium ("Priming Immunity at the Beginning of Life")
- the iMACnet project ("Genetically corrected iPSC-derived macrophages (i-MAC) for innovative gene therapeutic strategies")
- the Spemann Graduate School of Biology and Medicine
Recent News
MyPred website online (Erlacher group)
The homepage of the BMBF funded Research Consortium "MyPred: Optimizing care for young individuals with syndromes predisposing to myeloid malignancies”, coordinated by PD Dr. Miriam Erlacher, is now online here: www.mypred.de
New publication from the Corona-Kinderstudie
A new paper resulting from the Corona-Kinderstudie has just been published. The paper, entitled "Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May–August 2020" and published in Emerging Infectious Diseases, [...]
“Top paper of the Quarter” from the German Society of Gene Therapy for Roland Elling
Congratulations to Roland Elling, who recently had a publication selected as one of the German Society of Gene Therapy’s “Top Papers of the Quarter”! The co-authors include several other researchers associated with [...]